Literature DB >> 19189125

Turquoise to dark green organs at autopsy.

Arne Warth1, Benjamin Goeppert, Christian Bopp, Peter Schirmacher, Christa Flechtenmacher, Jürgen Burhenne.   

Abstract

We report the case of a 72-year-old man who died in septic shock following pancreatectomy. At autopsy, organs were discoloured with a rapid colour change from turquoise to dark green, especially of the myocardium. The patient had received 200 mg methylene blue (MB), i.v., for treatment of septic shock 90 min prior to death. Analysis of tissue samples by liquid extraction and liquid chromatography coupled to tandem mass spectrometry demonstrated different concentrations of MB and its metabolites azure A and B in the heart, lungs, kidneys, and liver. Our findings clearly demonstrate the relation of MB administration and organ discolouration at autopsy and shed a new light on MB distribution and accumulation in septic shock.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19189125     DOI: 10.1007/s00428-009-0734-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  11 in total

1.  Dark green blood in the operating theatre.

Authors:  Alana M Flexman; Giuseppe Del Vicario; Stephan K W Schwarz
Journal:  Lancet       Date:  2007-06-09       Impact factor: 79.321

2.  [Romanowsky dyes and romanowsky-Giemsa effect. 1. Azure B, purity and content of dye samples, association (author's transl)].

Authors:  E Zipfel; J R Grezes; W Seiffert; H W Zimmermann
Journal:  Histochemistry       Date:  1981

Review 3.  Use of methylene blue in sepsis: a systematic review.

Authors:  Edmund S H Kwok; Daniel Howes
Journal:  J Intensive Care Med       Date:  2006 Nov-Dec       Impact factor: 3.510

4.  High absolute bioavailability of methylene blue given as an aqueous oral formulation.

Authors:  Ingeborg Walter-Sack; Jens Rengelshausen; Heike Oberwittler; Juergen Burhenne; Olaf Mueller; Peter Meissner; Gerd Mikus
Journal:  Eur J Clin Pharmacol       Date:  2008-09-23       Impact factor: 2.953

5.  Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum.

Authors:  Kathrin Buchholz; R Heiner Schirmer; Jana K Eubel; Monique B Akoachere; Thomas Dandekar; Katja Becker; Stephan Gromer
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

6.  Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.

Authors:  Ricardo L Levin; Marcela A Degrange; Gustavo F Bruno; Carlos D Del Mazo; Daniel J Taborda; Jorge J Griotti; Fernando J Boullon
Journal:  Ann Thorac Surg       Date:  2004-02       Impact factor: 4.330

7.  Methylene blue administration in septic shock: a clinical trial.

Authors:  J C Preiser; P Lejeune; A Roman; E Carlier; D De Backer; M Leeman; R J Kahn; J L Vincent
Journal:  Crit Care Med       Date:  1995-02       Impact factor: 7.598

8.  Anti-tumoral and anti-inflammatory effects of biological stains.

Authors:  F Culo; D Sabolović; L Somogyi; M Marusić; N Berbiguier; L Galey
Journal:  Agents Actions       Date:  1991-11

9.  Quantification of cationic anti-malaria agent methylene blue in different human biological matrices using cation exchange chromatography coupled to tandem mass spectrometry.

Authors:  Jürgen Burhenne; Klaus-Dieter Riedel; Jens Rengelshausen; Peter Meissner; Olaf Müller; Gerd Mikus; Walter E Haefeli; Ingeborg Walter-Sack
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-01-26       Impact factor: 3.205

10.  Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine.

Authors:  Peter E Meissner; Germain Mandi; Boubacar Coulibaly; Steffen Witte; Théophile Tapsoba; Ulrich Mansmann; Jens Rengelshausen; Wolfgang Schiek; Albrecht Jahn; Ingeborg Walter-Sack; Gerd Mikus; Jürgen Burhenne; Klaus-Dieter Riedel; R Heiner Schirmer; Bocar Kouyaté; Olaf Müller
Journal:  Malar J       Date:  2006-10-08       Impact factor: 2.979

View more
  7 in total

1.  H2S induced coma and cardiogenic shock in the rat: Effects of phenothiazinium chromophores.

Authors:  Takashi Sonobe; Philippe Haouzi
Journal:  Clin Toxicol (Phila)       Date:  2015-05-12       Impact factor: 4.467

2.  The Effect of Methylene Blue and Its Metabolite-Azure I-on Bioenergetic Parameters of Intact Mouse Brain Mitochondria.

Authors:  A P Gureev; N A Samoylova; D V Potanina; V N Popov
Journal:  Biochem Mosc Suppl B Biomed Chem       Date:  2022-05-17

Review 3.  Methylene blue and its analogues as antidepressant compounds.

Authors:  Anzelle Delport; Brian H Harvey; Anél Petzer; Jacobus P Petzer
Journal:  Metab Brain Dis       Date:  2017-07-31       Impact factor: 3.584

4.  Use of methylene blue in hepatic arterial infusion pump resulting in serotonin syndrome. A case report.

Authors:  Cindy Yeoh; Luis Tollinche
Journal:  Anesthesiol Case Rep       Date:  2018-02-26

5.  Brain Protection by Methylene Blue and Its Derivative, Azur B, via Activation of the Nrf2/ARE Pathway in Cisplatin-Induced Cognitive Impairment.

Authors:  Ekaterina P Krutskikh; Daria V Potanina; Natalia A Samoylova; Mariya V Gryaznova; Irina S Sadovnikova; Artem P Gureev; Vasily N Popov
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-30

Review 6.  Efficacy and safety of methylene blue in the treatment of malaria: a systematic review.

Authors:  G Lu; M Nagbanshi; N Goldau; M Mendes Jorge; P Meissner; A Jahn; F P Mockenhaupt; O Müller
Journal:  BMC Med       Date:  2018-04-25       Impact factor: 8.775

7.  Azure B as a novel cyanide antidote: Preclinical in-vivo studies.

Authors:  Haouzi Philippe; McCann Marissa; Tubbs Nicole
Journal:  Toxicol Rep       Date:  2020-10-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.